UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6376
DB Gold Double Long ETN due February 15, 2038
DGP
$247M
| $73.6K | ﹤0.01% |
1,370
+770
| +128% | +$42K |
|
6377
Yatra Online
YTRA
$53.1M
| $73.5K | ﹤0.01% |
61,739
+59,200
| +2,332% | +$83.2K |
|
6378
Bioventus
BVS
$1.19B
| $73.5K | ﹤0.01% |
12,776
+11,471
| +879% | +$62.9K |
|
6379
Cohen & Co
COHN
$37.5M
| $73.4K | ﹤0.01% |
8,286
+7,833
| +1,729% | +$66.6K |
|
6380
Cue Biopharma
CUE
$114M
| $73.2K | ﹤0.01% |
1,967
-1,132
| -37% | -$56K |
|
6381
Roundhill Ball Metaverse ETF
METV
$219M
| $73K | ﹤0.01% |
5,597
-41
| -0.7% | -$509 |
|
|
RAPP
6382
Rapport Therapeutics
RAPP
$2.17B
| $72.7K | ﹤0.01% |
+3,127
| New | +$72.4K |
|
6383
Frequency Electronics
FEIM
$794M
| $72.5K | ﹤0.01% |
7,960
+5,960
| +298% | +$57K |
|
6384
Kyverna Therapeutics
KYTX
$479M
| $72.3K | ﹤0.01% |
9,644
-15,254
| -61% | -$233K |
|
|
TBHC
6385
DELISTED
The Brand House Collective
TBHC
| $72.3K | ﹤0.01% |
44,355
+36,837
| +490% | +$73.9K |
|
6386
Fidelity Cloud Computing ETF
FCLD
$122M
| $72.1K | ﹤0.01% |
+2,982
| New | +$71.1K |
|
|
BCOV
6387
DELISTED
Brightcove, Inc.
BCOV
| $72K | ﹤0.01% |
30,391
-74,904
| -71% | -$147K |
|
6388
Distillate US Fundamental Stability & Value ETF
DSTL
$2.04B
| $71.8K | ﹤0.01% |
+1,398
| New | +$72.4K |
|
6389
NLI Holdings
NL
$307M
| $71.8K | ﹤0.01% |
11,911
-964
| -7% | -$7.2K |
|
|
VIOT
6390
Viomi Technology
VIOT
$50.1M
| $71.8K | ﹤0.01% |
+77,134
| New | +$55.9K |
|
6391
Outdoor Holding Co
POWW
$251M
| $71.8K | ﹤0.01% |
42,720
-212,804
| -83% | -$512K |
|
6392
Dave Inc
DAVE
$4.2B
| $71.7K | ﹤0.01% |
2,366
+1,772
| +298% | +$72K |
|
|
BGFV
6393
DELISTED
Big 5 Sporting Goods
BGFV
| $71.7K | ﹤0.01% |
24,219
-2,142
| -8% | -$7.06K |
|
|
NXN
6394
DELISTED
Nuveen New York Tax-Free Income Portfolio
NXN
| $71.5K | ﹤0.01% |
6,113
+235
| +4% | +$2.74K |
|
6395
EverCommerce
EVCM
$1.88B
| $71.5K | ﹤0.01% |
6,509
-17,796
| -73% | -$172K |
|
6396
Bridgewater Bancshares
BWB
$599M
| $71.3K | ﹤0.01% |
6,144
-14,485
| -70% | -$166K |
|
6397
Nektar Therapeutics
NKTR
$2.54B
| $71.3K | ﹤0.01% |
3,834
+3,621
| +1,700% | +$76.3K |
|
6398
BK Technologies
BKTI
$290M
| $71.2K | ﹤0.01% |
5,566
+566
| +11% | +$7.73K |
|
6399
authID Inc
AUID
$10.9M
| $71K | ﹤0.01% |
6,839
+305
| +5% | +$2.49K |
|
6400
BNY Mellon US Mid Cap Core Equity ETF
BKMC
$672M
| $70.9K | ﹤0.01% |
2,256
+1,953
| +645% | +$61.5K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.